Relief you can rely on ha.com

Relief you can rely on

Investor Presentation | September 2020

Forward Looking Statement

Certain statements in this presentation constitute forward-looking statements within the meaning of applicable Canadian and United States securities legislation (collectively herein referred to as "forward-looking statements"), which can often be identified by words such as "will", "may", "estimate", "expect", "plan", "project", "intend", "anticipate" and other words indicating that the statements are forward-looking. Such forward-looking statements are expectations only and are subject to known and unknown risks, uncertainties and other important factors, including, but not limited to, risk factors included in this presentation, that could cause the actual results, performance or achievements of Trulieve Cannabis Corp. (The "Company" or "Trulieve") or industry results to differ materially from any future results, performance or achievements implied by such forward-looking statements. Such risks and uncertainties include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses; engaging in activities which currently are illegal under United States federal law and the uncertainty of existing protection from United States federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including United States state-law legalization, particularly in Florida, due to inconsistent public opinion, perception of the medical-use and adult-use cannabis industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; reliance on management; and the effect of capital market conditions and other factors on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements.

Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forwardlooking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

Historical statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. In this regard, certain financial information contained herein has been extracted from, or based upon, information available in the public domain and/or provided by the Company. In particular historical results of the Company should not be taken as a representation that such trends will be replicated in the future. No statement in this document is intended to be nor may be construed as a profit forecast. For further details on the forward-looking statements included in this presentation, see "Forward-Looking Information" in the final base shelf 2 prospectus of the Company dated May 14, 2019 (the "Final Base Shelf Prospectus") and available on the Company's SEDAR profile at . All of the forward-looking information contained in this presentation is expressly qualified by the foregoing cautionary statements. Investors should read the Company's public filings and consult their own professional advisors to ascertain and assess the income tax, legal, risk factors and other aspects of their investment in any securities of the Company.

Forward-looking statements made in this document are made only as of the date of their initial publication, and the Company undertakes no obligation to publicly update any of these forward-looking statements as actual events unfold.

2 ? 2020 Trulieve. All Rights Reserved.

Overview

COMPANY MISSION Provide the highest level of cannabis products and customer experience through authentic and reciprocal relationships

3 ? 2020 Trulieve. All Rights Reserved.

Founded in 2015 First dispensary in 2016 ~3400* employees 4 states (FL, CA, MA, CT) 59* stores (FL, CA, CT) 1.8M face-to-face transactions in 2019 ~ 1.8M* sq. ft. cultivation in FL Profitable since 2017

**AsAos foSfeDpetceemmbbeerr1301, ,22002109

Sustained Profitable Growth

~50%

of medical cannabis dispensed in Florida*

*Trulieve Estimate

SEP 2018

Entered public markets

CSE: TRUL

OTCQX: TCNNF

Seed-to-sale

Vertically integrated operations

Acquisitions

Massachusetts California Connecticut

~50%

Flower by weight*

*Trulieve Estimate

366,058

Dedicated & growing Florida consumer base

as of 08/31/2020

~5100

4 week average of new Floridian

patients August 2020

4 ? 2020 Trulieve. All Rights Reserved.

Cost Competitive Cultivation and High Yield Extraction

Focused on high quality products and consumer experience

Cultivation & Extraction

1,780,408 sq ft of cultivation capacity Can produce 74,631 kg annually

(As of 08/31/20)

640,408 Indoor Cultivation* 1,140,000 Greenhouse*

*Max estimate turns of 5 and 2 respectively

5 ? 2020 Trulieve. All Rights Reserved.

Branded Product Development

522 SKUs of private label, medical grade cannabis consumer products

-- Super-critical ethanol and CO2 extraction and distillation processes

to produce concentrates --

Infrastructure ready to support BHO extraction methods

Retail Sales

57 Florida retail locations plus a statewide delivery program

-- Continuing to grow in 2020 to

maintain lead in Florida --

Targeting 68 stores in US by Year End

Go-To-Market Strategy

Large & growing product line

522 SKUs with multiple concentration ratios and strains

Powerful brand name partnerships

Helping our market grow faster

Flower

Capsules Vape Cartridge Crumble

Shatter

Nasal Spray Oral Syringe

Building trust with local brands

Local Florida brands focused on Florida-based strain profiles

Wholesale distribution

Plan to extend our Trulieve brand in approved states

6 ? 2020 Trulieve. All Rights Reserved.

Massachusetts

California

Florida

In future

Connecticut

In future

Largest Dispensary Network in Florida

7,300* patients served in stores daily

177,651 sq ft of retail space

as of 8/31/20

--

First mover advantage

as first licensed company in Florida

--

First cannabis dispensary

in 19 of 29 municipalities

--

Home delivery service

Efficient statewide network

7 ? 2020 Trulieve. All Rights Reserved.

*On average in 2019

57 dispensaries in Florida

Pensacola 1&2

Tallahassee Ft. WalDtoenstin

Panama City

Fernandina Beach

Jacksonville x2 Orange Park

St. Augustine

Gainesville Ocala Lady Lake

Palm Coast Daytona Beach Edgewater

Longwood New PBorrotWoRkiecsshvlieellyyeChaOperllando x4

Titusville

Largo Tarpon Springs

CTleaamrLwpaakaetxel3arnd

Melbourne

St. Petersburg x2

Englewood

Bradenton PoSrCtaVarCapehsenaoirCtclaoeotrtaelCapeNFPtCoo.orMrtrthaySlet rLsucy

Bonita Springs Dania Beach

Miami

VFeSttrPuoiaeBrretcaech West Palm Boynton Deerfield Ft. Lauderdale Miami

Dadeland

Key West

Statewide Home Delivery Program

Next-day delivery service

Fleet of ~200 vehicles

--

Call center support

Average 4500 interactions daily in Q2

--

Growing E-commerce channels

58K+

Deliveries to patients in 2019

8 ? 2020 Trulieve. All Rights Reserved.

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download